|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.29 USD | +1.83% |
|
+1.48% | -30.20% |
| 06-02 | Daxor Says Received US Patent for Remote Blood Volume Monitor Technology | MT |
| 04-26 | 5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
Breakdown by Business Segment (USD)
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Geographical Revenue Distribution History
Geographical breakdown of sales (USD)
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 278K | 232K | 163K | 120K | 26.69K | |||||
Total Assets | 24.98M | 30.26M | 34.87M | 36.63M | 46.01M | |||||
Interest Expense | -19.6K | -72.45K | -49.1K | -85.09K | -15.96K | |||||
Income Tax Expense | - | - | - | - | - | |||||
Net Income | 4.75M | 5.18M | 281K | 536K | 9.17M | |||||
EBT | 4.75M | 5.18M | 281K | 536K | 9.17M |
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Financials Daxor Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
